These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30034947)

  • 21. Evaluating the utility of a high throughput thiol-containing fluorescent probe to screen for reactivity: A case study with the Tox21 library.
    Patlewicz G; Paul-Friedman K; Houck K; Zhang L; Huang R; Xia M; Brown J; Simmons SO
    Comput Toxicol; 2023 May; 26():. PubMed ID: 37388277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups.
    Metz JT; Huth JR; Hajduk PJ
    J Comput Aided Mol Des; 2007; 21(1-3):139-44. PubMed ID: 17340041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How to Triage PAINS-Full Research.
    Dahlin JL; Walters MA
    Assay Drug Dev Technol; 2016 Apr; 14(3):168-74. PubMed ID: 26496388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical removal of background signals from high-throughput (1)H NMR line-broadening ligand-affinity screens.
    Worley B; Sisco NJ; Powers R
    J Biomol NMR; 2015 Sep; 63(1):53-8. PubMed ID: 26156049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers.
    Avonto C; Chittiboyina AG; Rua D; Khan IA
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):177-84. PubMed ID: 26455772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Small-Molecule Inhibitors of the HuR/RNA Interaction Using a Fluorescence Polarization Screening Assay Followed by NMR Validation.
    Wang Z; Bhattacharya A; Ivanov DN
    PLoS One; 2015; 10(9):e0138780. PubMed ID: 26390015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.
    Stockman BJ; Kaur A; Persaud JK; Mahmood M; Thuilot SF; Emilcar MB; Canestrari M; Gonzalez JA; Auletta S; Sapojnikov V; Caravan W; Muellers SN
    J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Throughput Quantitative Intrinsic Thiol Reactivity Evaluation Using a Fluorescence-Based Competitive Endpoint Assay.
    Sameshima T; Miyahisa I; Yamasaki S; Gotou M; Kobayashi T; Sakamoto J
    SLAS Discov; 2017 Oct; 22(9):1168-1174. PubMed ID: 28426937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RAMPED-UP NMR: multiplexed NMR-based screening for drug discovery.
    Zartler ER; Hanson J; Jones BE; Kline AD; Martin G; Mo H; Shapiro MJ; Wang R; Wu H; Yan J
    J Am Chem Soc; 2003 Sep; 125(36):10941-6. PubMed ID: 12952475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput assays for promiscuous inhibitors.
    Feng BY; Shelat A; Doman TN; Guy RK; Shoichet BK
    Nat Chem Biol; 2005 Aug; 1(3):146-8. PubMed ID: 16408018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of Biophysics in High-Throughput Screening Hit Validation.
    Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
    J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Robust NMR screening for lead compounds using tryptophan-containing proteins.
    Bista M; Kowalska K; Janczyk W; Dömling A; Holak TA
    J Am Chem Soc; 2009 Jun; 131(22):7500-1. PubMed ID: 19422216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identifying actives from HTS data sets: practical approaches for the selection of an appropriate HTS data-processing method and quality control review.
    Shun TY; Lazo JS; Sharlow ER; Johnston PA
    J Biomol Screen; 2011 Jan; 16(1):1-14. PubMed ID: 21160066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-Throughput Screening (HTS) by NMR Guided Identification of Novel Agents Targeting the Protein Docking Domain of YopH.
    Bottini A; Wu B; Barile E; De SK; Leone M; Pellecchia M
    ChemMedChem; 2016 Apr; 11(8):919-27. PubMed ID: 26592695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology.
    Blagg J; Workman P
    Cancer Cell; 2017 Jul; 32(1):9-25. PubMed ID: 28697345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward the quantum chemical calculation of nuclear magnetic resonance chemical shifts of proteins.
    Frank A; Onila I; Möller HM; Exner TE
    Proteins; 2011 Jul; 79(7):2189-202. PubMed ID: 21557322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMR-based platform for fragment-based lead discovery used in screening BRD4-targeted compounds.
    Yu JL; Chen TT; Zhou C; Lian FL; Tang XL; Wen Y; Shen JK; Xu YC; Xiong B; Zhang NX
    Acta Pharmacol Sin; 2016 Jul; 37(7):984-93. PubMed ID: 27238211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
    Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
    Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and validation of novel small molecule disruptors of HuR-mRNA interaction.
    Wu X; Lan L; Wilson DM; Marquez RT; Tsao WC; Gao P; Roy A; Turner BA; McDonald P; Tunge JA; Rogers SA; Dixon DA; Aubé J; Xu L
    ACS Chem Biol; 2015 Jun; 10(6):1476-84. PubMed ID: 25750985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.